摩根士丹利分析师Terence Flynn上调Jan 10, Wall Street analysts have updated their stock ratings today including $Boston Scientific (BSX.US)$ and $Gilead Sciences (GILD.US)$.
Upgrades:
Deutsche Bank analyst Pito Chickering upgrades $Boston Scientific (BSX.US)$ to buy rating, and adjust the target price from USD78 to USD108.
Morgan Stanley analyst Terence Flynn upgrades $Gilead Sciences (GILD.US)$ to buy rating, and adjust the target price from USD79 to USD113.
Piper Sandler analyst Anna Andreeva upgrades $Nike (NKE.US)$ to buy rating, and adjust the target price from USD80 to USD90.
Downgrades:
Wells Fargo analyst Mohit Bansal maintains $Regeneron Pharmaceuticals (REGN.US)$ with buy rating, and adjust the target price from USD1050 to USD900.
Wells Fargo analyst Ike Boruchow downgrades $Ross Stores (ROST.US)$ to hold rating, and maintains the target price of USD165.
For more trending U.S. stock ratings today, refer to the chart below: